Elicio Therapeutics Inc. (ELTX) — Free Cash Flow Generation Index

Latest as of June 2022: 0.91x

Elicio Therapeutics Inc. (ELTX) has a Free Cash Flow Generation Index of 0.91x as of June 2022. Free cash flow of $5.58 Million represents 1% of operating cash flow ($6.14 Million). Explore ELTX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

$5.58 Million
USD

Operating Cash Flow

$6.14 Million
USD

Capital Expenditures

$559.00K
USD

Elicio Therapeutics Inc. Free Cash Flow Generation Index (2012–2013)

Historical FCF Generation Index trend for Elicio Therapeutics Inc. across 2 annual periods. For the full cash flow conversion analysis, see ELTX operating cash flow.

Annual Free Cash Flow Generation for Elicio Therapeutics Inc. (2012–2013)

Year-by-year Free Cash Flow Generation Index for Elicio Therapeutics Inc.. Check Elicio Therapeutics Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2013 0.99x $1.87 Million $1.89 Million $17.57K ▲ +3.7%
2012 0.96x $1.02 Million $1.07 Million $47.73K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).